Skip to main content
OpenTrials

Clinical trial condition

Unresectable Epithelioid Hemangioendothelioma

Explore clinical trials studying Unresectable Epithelioid Hemangioendothelioma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Unresectable Epithelioid Hemangioendothelioma trial results

Completed

Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery

NCT03148275

Conditions
Hemangioendothelioma, Hemangioendothelioma, Epithelioid, Hemangioma, +6 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
View all 36 locations
View Trial Details

Related conditions